Exhibit

We hereby consent to the incorporation by reference in the Registration Statements on Forms S‑8 (Nos. 333-223433, 333-216342, 333-209949, 333-208543, 333-203235, 333-198499, and 333-193963) and the Registration Statements on Forms S-3 (Nos. 333-210001, 333-207469 and 333-221911) of Revance Therapeutics Inc. of our report dated February 28, 2019 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.